Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/myc.13185 http://scihub22266oqcxt.onion/10.1111/myc.13185 32965042!7646269!32965042     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32965042&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mycoses 2020 ; 63 (12): 1368-1372 Nephropedia Template TP {{tp|p=32965042|t=2020. Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City |pdf=|usr=}}{{32965042}} gab.com Text Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City JO: Mycoses http://www.kidney.de/pget.php?&tw=1&pmid=32965042 #FOAvip BACKGROUND: Critically ill patients with coronavirus disease-2019 (COVID-19) are at the theoretical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors. PATIENTS/METHODS: We aimed to describe the clinical features of COVID-19-associated pulmonary aspergillosis at a single centre in New York City. We performed a retrospective chart review of all patients with COVID-19 with Aspergillus isolated from respiratory cultures. RESULTS: A total of seven patients with COVID-19 who had one or more positive respiratory cultures for Aspergillus fumigatus were identified, all of whom were mechanically ventilated in the ICU. Four patients were classified as putative IPA. The median age was 79 years, and all patients were male. The patients had been mechanically ventilated for a mean of 6.8 days (range: 1-14 days) before Aspergillus isolation. Serum galactomannan level was positive for only one patient. The majority of our cases received much higher doses of glucocorticoids than the dosage with a proven mortality benefit. All four patients died. CONCLUSIONS: Vigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID-19. Twit Text FOAVip Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City ????Mycoses http://www.kidney.de/pget.php?&tw=1&pmid=32965042 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32965042 #FOAvip English Wikipedia <ref>{{Cite pmid|32965042}}</ref> Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City #MMPMID32965042 Mitaka H; Perlman DC; Javaid W; Salomon N Mycoses 2020[Dec]; 63 (12): 1368-1372 PMID32965042show ga BACKGROUND: Critically ill patients with coronavirus disease-2019 (COVID-19) are at the theoretical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors. PATIENTS/METHODS: We aimed to describe the clinical features of COVID-19-associated pulmonary aspergillosis at a single centre in New York City. We performed a retrospective chart review of all patients with COVID-19 with Aspergillus isolated from respiratory cultures. RESULTS: A total of seven patients with COVID-19 who had one or more positive respiratory cultures for Aspergillus fumigatus were identified, all of whom were mechanically ventilated in the ICU. Four patients were classified as putative IPA. The median age was 79 years, and all patients were male. The patients had been mechanically ventilated for a mean of 6.8 days (range: 1-14 days) before Aspergillus isolation. Serum galactomannan level was positive for only one patient. The majority of our cases received much higher doses of glucocorticoids than the dosage with a proven mortality benefit. All four patients died. CONCLUSIONS: Vigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID-19. |Aged[MESH] |Aged, 80 and over[MESH] |Aspergillus fumigatus/*isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/therapy[MESH] |Fatal Outcome[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Invasive Pulmonary Aspergillosis/*complications/microbiology/therapy[MESH] |Male[MESH] |New York City/epidemiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/therapy[MESH] |Respiration, Artificial[MESH] |Retrospective Studies[MESH]Putative invasive pulmonary aspergillosis in critically ill patients w(epmc).pdf DeepDyve Pubget Overpricing